Dr. Andrew Dalovisio is the Director of the Myeloma, Lymphoma, and Cellular Therapy Program at Mary Bird Perkins Cancer Center in Baton Rouge. Dr. Dalovisio is a native of New Orleans, Louisiana. He graduated from Jesuit High School and went on to attend Washington and Lee University in Virginia. He received a Doctor of Medicine degree from Louisiana State University Health Sciences Center in Shreveport, Louisiana. He completed an internal medicine residency followed by a hematology/oncology fellowship at Rush University Medical Center in Chicago, Illinois. Dr. Dalovisio is a member of the American Society of Hematology, the American Society of Transplantation and Cellular Therapy, the International Myeloma Society, and American Society of Clinical Oncology. His professional interests include plasma cell disorders and lymphomas.
Mary Bird Perkins Cancer Center Louisiana Hematology Oncology Associates
Residency: Internal Medicine Residency; Rush University Medical Center; Chicago, IL Fellowship: Hematology and Oncology Fellowship; Rush University Medical Center; Chicago, IL Inpatient Bone Marrow Transplant Unit; Fred Hutchinson Cancer Center; Seattle, WA
Bachelors: Washington & Lee University; Lexington, VA Doctorate: Louisiana Sate University Health Sciences Center; Shreveport, LA
American Board of Internal Medicine – Internal Medicine American Board of Internal Medicine – Hematology American Board of Internal Medicine – Medical Oncology
